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The prevention of self-harm is an international public health priority. It is vital to identify at-risk
populations, particularly as self-harm is a risk factor for suicide. This study aims to examine the risk of
self-harm in people with vertebral fractures
Methods
Retrospective cohort study. Patients with vertebral fracture were identi ed within the Clinical Practice
Research Datalink and matched to patients without fracture by sex and age. Incident self-harm was
de ned by primary care record codes following vertebral fracture. Overall incidence rates (per 10,000
person-years (PY)) were reported. Cox regression analysis determined risk (hazard ratios (HR), 95%
con dence interval (CI)) of self-harm compared to the matched unexposed cohort. Initial crude analysis
was subsequently adjusted and strati ed by median age and sex.
Results
The number of cases of vertebral fracture was 16,293, with a matched unexposed cohort of the same
size. Patients were predominantly female (70.1%), median age was 76.3 years. Overall incidence of self-
harm in the cohort with vertebral fracture was 12.2 (10.1, 14.8) /10,000 PY. There was an initial crude
association between vertebral fracture and self-harm, which remained after adjustment (HR 2.4 (95%CI
1.5, 3.6). Greatest risk of self-harm was found in those with vertebral fractures who were aged below 76.3
years (3.2(1.8, 5.7)) and male (3.9(1.8, 8.5)).
Conclusions
Primary care patients with vertebral fracture are at increased risk of self-harm compared to people
without these fractures. Male patients aged below 76 years of age appear to be at greatest risk of self-
harm. Clinicians need to be aware of the potential for self-harm in this patient group.
Background
The prevention of self-harm is an international public health priority[1, 2], but in the UK between 2001 to
2013, there was an observed increase in presentations of self-harm to primary care for both men and
women[2]. It is vital to identify populations at risk of self-harm, particularly as this is a risk factor for
suicide[3]. The World Health Organisation (WHO) have recommended that non-specialist healthcare
professionals could evaluate the self-harm potential of patients who present with symptoms of chronic
pain and/or depression[4]. Mental ill-health, notably a history of a depressive disorders or borderline
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personality disorder (BPD) are risk factors for self-harm[5, 6], and although pain is on the causal pathway
for depression, pain is also an independent risk factor for self-harm[7, 8] and is linked with trauma,
another prominent risk factor[9]. As such, we posit that patients with osteoporotic fractures (particularly
vertebral fractures[10]), have the potential to be more vulnerable to self-harm (de ned here as non-
suicidal self-harm) due to experiencing many of the same risk factors as patients who self-harm.
Vertebral fractures may result in physical impairments, such as kyphosis and height loss, and have also
been linked with psychological sequelae including anxiety[11] and depression[12] As many as 20% of the
elderly population are affected by vertebral fractures. This fracture type has a well-documented
association with reduced quality of life and increased disability[13, 14], both of which have been reported
as motivators for self-harm in older adults[15]. Furthermore, osteoporosis shares several risk factors with
depression, such as smoking, drinking and immobility[16]. Vertebral fractures have also been associated
with suicide[17, 18]. Therefore, we hypothesise that the burden presented by such risk factors, either
individually or synergistically, in patients with vertebral fracture would increase the risk of subsequent
self-harm.
We have recently reported increased risk of self-harm in people with  bromyalgia, rheumatoid arthritis,
and osteoarthritis[19], and similarly, the risk of self-harm has previously been examined in osteoporosis
and back pain. Using CPRD data, Webb et al., found increased risk of self-harm in females, but not males,
with osteoporosis, and in both genders with back pain[7]. They did not however, look at the vertebral
fracture population, meaning that risk of self-harm in people with vertebral fractures is still unknown. Our
aim was to examine the risk of self-harm in patients with vertebral fractures in a primary care population
and to examine the role of age and gender on such risk.
Methods
Study design
Using the Clinical Practice Research Datalink (CPRD), we undertook a matched retrospective cohort study
using anonymised Read-coded (clinical coding system used in UK primary care) patient data [19]. CPRD
is a database of primary care records covering around 7% of the UK population. This coded consultation
and prescription data is representative of the UK population, in relation to sex, age and ethnicity[20].
Study Population
We identi ed patients aged ≥ 18 years with vertebral fracture between 1st January 1990 and 31st
December 2016. Sample identi ed was achieved by speci c Read codes, based on and re ned from an
internal code list repository (www.keele.ac.uk/mrr). An index date was assigned to each patient
corresponding to the date of their diagnosis.
A matched unexposed cohort was constructed as a comparison, this included primary care patients
without a previous coded diagnosis of vertebral fracture. No exclusions were made based on the
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presence of other chronic diseases, including osteoporosis. Cases were grouped by gender and 10-year
age range and then frequency matched to unexposed patients. Each control was assigned a pseudo-
index date, generated at random from between their 18th birthday and study end date. All individuals
were subsequently examined for a Read code which identi ed self-harm. The codes used were based on
both the Read code list used in previous CPRD research[2] and a review (by clinical members of the
research team) of all self-harm Read codes available for selection within primary care electronic health
records (Code list available at www.keele.ac.uk/mrr upon request). Our self-harm de nition was based on
the presence of any relevant non-suicidal self-harm code and did not specify method of self-harm, all
suicide related codes were removed. Patients were excluded if their self-harm code occurred prior to their
index date. Incidence was based only on the  rst self-harm code reported post vertebral fracture.
Statistical Analysis
Descriptive statistics were used to characterise the vertebral fracture cohort, including age, gender,
practice-level deprivation (the socio-economic status of households in a de ned geographical area where
the practice is located), previous diagnosis for anxiety and/or depression, BMI, smoking status (never/ex-
smoker or current) and alcohol consumption (1–9 or ≥ 10 drinks per week) and (the latter three de ned
by the closest value recorded before the index date). The incidence rate of self-harm per 10,000 person-
years (PY) was determined for vertebral fracture from 01/01/1990 to 31/12/2016. Patients contributed
data after the latest of three events: (1) the study start date, (2) the date they registered at a participating
practice, plus 6 months or (3)the ‘up-to-standard’ date (the practice reached internal quality standards.
Cox proportional-hazards regression analysis was used for the time-period of 1990 to 2016. Crude hazard
ratios (HR) were reported with 95% con dence intervals (CIs) to examine the association between the
presence of vertebral fracture and subsequent incidence of self-harm compared to the matched
unexposed cohort. Adjusted analysis was then undertaken, accounting for age, gender, smoking status,
alcohol consumption, BMI, practice-level deprivation and, anxiety and depression. Cases with missing
data for BMI, smoking status and alcohol consumption were included within analysis using a missing
category approach to avoid making the assumption they were missing at random, which is unlikely to be
the case. This approach provides transparency of data and our analytical approach. Imputation was not
considered sensible in this case, because data were unlikely to be missing at random[21]. Schoenfeld’s
residuals were examined to determine the proportionality of hazards for each model. Where variables
showed evidence of non-proportionality, they were included as time varying covariates. Further analyses
were conducted, stratifying by median age of the exposed cohort and gender. We de ned our
dichotomized age subgroups as those patients < 76.3 years or ≥ 76.3 years. Data were analyzed with
Stata software (version 15.1, StataCorp, College Station, TX, USA).
This study is based in part on data from the CPRD, obtained under license from the UK Medicines and
Healthcare products Regulatory Agency (MHRA). The data is from patients who have provided informed
consent and collected by the NHS as part of their care and support. This study was approved by the
CPRD Independent Scienti c Advisory Committee (reference number 18_018R3) prior to release of




The number of cases of vertebral fracture was 16,293, with a matched unexposed cohort of the same
size. The mean age in the exposed cohort was 74.8 (similar in the unexposed cohorts) and the majority of
patients were female (70.1%) and. The prevalence of anxiety and depression in the exposed cohort was
approximately double that seen in the unexposed (Table 1).
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Table 1







Mean age at index (SD) 74.84 (10.7) 74.31 (11.2) < 0.001
Females 11,549 (70.1) 11,549 (70.1) 1.000
Median years follow-up (IQR) 4.1 (2.3, 7.1) 4.8 (2.5. 8.7) < 0.001
Deprivation status      
  Q1 (Least deprived) 3763 (23.1) 3059 (18.8) < 0.001
  Q2 2911 (17.9)) 2786 (17.1)  
  Q3 2947 (18.1) 3335 (20.5)  
  Q4 3284 (20.1) 3603 (22.1)  
  Q5 (Most deprived) 3388 (20.8) 3510 (21.5)  
BMI (kg/m2)      
  Underweight (< 18.5) 590 (3.6) 136 (0.8) < 0.001
  Healthy weight (< 18.5–24.9) 6036 (37.1) 2136 (13.1)  
  Overweight (25.0-29.9) 4955 (30.4) 2213 (13.6)  
  Obese (> 30.0) 2467 (15.1) 1267 (7.8)  
  Missing 2245 (13.8) 10,541 (64.7)  
Smoking      
  Never/Ex smoked 5656 (34.7) 12,908 (79.2) < 0.001
  Current smoker 962 (5.9) 2373 (14.6)  
  Missing 9675 (59.4) 1012 (6.2)  
Alcohol consumption      
  Never/Ex-drinker 1719 (10.6) 3881 (23.8) < 0.001
  Current 1–9 drinks per week 3387 (20.8) 7879 (48.4)  
  Current > = 10 drinks per week 663 (4.1) 2240 (13.7)  
  Missing 10,524 (64.6) 2293 (14.1)  







Depression 4505 (27.7) 2330 (14.3) < 0.001
Incidence and risk of self-harm in Vertebral fractures
Overall incidence of self-harm in the cohort with vertebral fractures was 12.2 (95%CI 10.1, 14.8) per
10,000 PY. When strati ed by age, the incidence was 13.4 (95%CI 10.4,17.1) in those < 76.3 years and
10.8 (95%CI 8.0, 14.7) in those ≥ 76.3 years. When strati ed for gender, incidence was 17.7 (95%CI 12.6,
23.2) and 10.3 (95%CI 8.1, 13.2) for males and females respectively (Table 2).
Table 2
Risk of self-harm associated with vertebral fracture











Total 104 12.2 (10.1,
14.8)




Age                
  < 76.3 63 13.4 (10.4,
17.1)








Gender                
  Male 41 17.1 (12.6,
23.2)








*adjusted for age, BMI, smoking status, alcohol consumption, anxiety, depression and practice-level
deprivation. Bold = statistically signi cant (p < = 0.05).
When associations were examined, there was a signi cant crude association between vertebral fracture
(HR 2.3 (95%CI 1.7, 3.3)) and subsequent self-harm compared to having no recorded vertebral fracture.
This association was retained after adjustment (HR 2.4 (95%CI 1.5, 3.6) (Table 2). After stratifying at the
median age, we found there to be a marked difference between the crude risk of self-harm across the < 
76.3 and ≥ 76.3 years strata for the vertebral fractures cohort (HR 3.1 (95%CI 1.9, 4.8) and HR 1.7 (95%CI
1.0, 2.7) respectively). This difference in risk of self-harm between the age strata became greater after
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adjustment and a signi cant association was only retained for those younger than 76 years (< 76.3 years:
HR 3.1 (95%CI 1.9, 4.8), ≥ 76.3 years: (HR 1.7 (95%CI 0.9,3.3)).
Crude analysis found males with vertebral fractures to be almost four times more likely to self-harm
compared to those without a previous vertebral fractures (HR 4.0 (95%CI 2.1, 7.7)) and females to be
almost two times as likely to self-harm (HR 1.8 (95%CI 1.2, 2.7)). These signi cant associations were
altered little by adjustment, (Males: HR 3.9 (95%CI 1.8, 8.5); Females HR 1.9 (95%CI 1.1, 3.2)) and
remained statistically signi cant (Table 2).
Discussion
Although the absolute incidence of self-harm was low, we found that primary care patients with vertebral
fractures are at increased risk of self-harm compared to matched patients without fractures. Age and
gender were also found to be effect modi ers, with patients aged below < 76 years and male strata
showing an increased risk of self-harm in those with vertebral fractures.
Overall, in this study, male patients with vertebral fractures showed the greatest risk of self-harm with a 4-
fold increase compared to an age matched unexposed cohort. This contrasts with the trend for higher
rates of self-harm seen in females in the general population, and the previous study using CPRD which
examined risk of self-harm in osteoporosis[2, 7]. This may be explained by differences in the experiences
and perceptions of males with vertebral fractures, or in clinical risk factors. Males who display low bone
density, and increased fracture risk, often have an underlying cause such as medication use (steroids),
hormone related conditions such as hypogonadism or lifestyle behaviours, such as smoking[22–24]. The
presence of multimorbidity is associated with higher instances of self-harm and mental illness diagnosis,
whilst behavioral factors such as smoking are risk factors for depression in and of themselves[25, 26].
Further, conditions such as hypogonadism which can increase fracture risk are linked themselves, with
mental ill-health in men[27]. In a study exploring males experience of having osteoporotic vertebral
fractures, osteoporosis was perceived as an old women’s disease[28]. A gendered societal view of
fractures relating to osteoporosis/low bone mineral density (BMD) can cause a threat to masculinity,
leading to avoidance of seeking help or consulting healthcare practitioners[28–30], disbelief and di culty
discussing with others. This relates to research on males with chronic pain who reported that they
avoided seeking health care, and expectations of being ‘stronger’ or more ‘able to cope’ were prevalent in
those who self-harmed[31]. Furthermore, men can experience delayed diagnosis and treatment when it
comes to osteoporosis, due to health care professional knowledge and gender differences in licensing of
anti-osteoporotic medications[32] with males  nding this “depressing” and “frustrating”[28].
Age contributed to the risk of self-harm, as those under the age of 76 with vertebral fractures were found
to be three times more likely to self-harm as those in the matched population. Webb et al., similarly
reported signi cant odds ratios in those < 60 years with osteoporosis, as well as for cancer, coronary heart
disease, stroke, and COPD[7]. Though not explaining the identi ed association between vertebral fracture
and self-harm, several examined covariates (i.e. anxiety and depression) were signi cantly associated
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with self-harm. However, there remain other factors which may play a role. Vertebral fractures are known
to cause pain which is a risk factor in and of itself for self-harm[8], as is use of some pain medications,
and vertebral fractures have been linked with other factors which may mediate the risk, including
decreases in health-related quality of life, loss of independence, low self-esteem and social problems[33–
35].
Strengths and limitations
This is the  rst study to examine vertebral fracture as a risk factor for incident self-harm. Our use of a
large UK primary care dataset has allowed us to examine the incidence of self-harm as well as examine
the role of age and gender. The accuracy of vertebral fracture codes has previously been validated[35]
and our analysis also takes account of clinically recorded depression, a key risk factor for self-harm.
Several limitations to our work do need to be considered. First, our methods do not facilitate the
identi cation of people with uncoded vertebral fractures. Vertebral fractures are often asymptomatic or
undiagnosed and do not come to clinical attention[36], with one study reporting 80% of women with
vertebral fracture being undiagnosed post radiographic investigation. Although the majority of vertebral
fractures are likely to be a result of low trauma in this age group, the degree of trauma is not recorded. We
have also not addressed the question of risk of self-harm in people with osteoporosis and/or other types
of fragility fracture; osteoporosis is known to be poorly coded in CPRD with < 30% of those receiving
osteoporosis medication having an osteoporotic code[37] and we hypothesized that of all the fragility
fractures, vertebral fractures were more likely to be associated with chronic pain and therefore self-harm
risk. We were not able to examine mechanisms in this study; for example, pain is likely to be a key
contributory factor in the risk of self-harm[32]; however, it could not be determined from consultation
record data. Furthermore, it remains unclear to what extent use of medications and treatments in uence
the risk of self-harm. Our original intention within this analysis had also been to examine year-on-year
incidence and breakdown the age strata as well, as the used strata form wide age groups, but numbers
were too small for such analysis. We also found large proportions of missing data for BMI, smoking and
alcohol consumption within the CPRD dataset, particularly in the unexposed patients. As such data is not
“missing at random”, we were unable to impute these missing values. However, we included missing data
as a separate category in our models and reported the extent of missing data in descriptive tables to
ensure transparency. Finally, though our adjustment for anxiety and depression would have captured the
largest proportion of mental health conditions, there remain conditions we were unable to adjusted for.
Importantly this includes BPD, which can be underreported in non-specialist settings[38] and therefore the
small sample which reported self-harm meant identifying any related codes within this primary care
dataset would be unlikely.
Conclusion
Although the absolute incidence is low, people with vertebral fractures have increased risk of self-harm
compared to matched unexposed patients. Both age and gender are strong effect modi ers, with males
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aged below 76 years being at increased risk. Further work is needed to explore the mechanisms of this
association and develop appropriate interventions. In the meantime, healthcare professionals need to be
vigilant, explore mood, assess risk, and offer appropriate support, management and referrals and
signposting especially to younger people and males with vertebral fractures.
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